CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023
April 14, 2023 at 09:59 am EDT
CNBX Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended February 28, 2023. For the second quarter, the company reported net loss was USD 2.62 million compared to USD 1.24 million a year ago. Basic loss per share from continuing operations was USD 1.33 compared to USD 1.01 a year ago. Diluted loss per share from continuing operations was USD 1.33 compared to USD 1.01 a year ago.
For the six months, net loss was USD 2.98 million compared to USD 2.56 million a year ago. Basic loss per share from continuing operations was USD 1.42 compared to USD 2.27 a year ago. Diluted loss per share from continuing operations was USD 1.42 compared to USD 2.27 a year ago.